Search Results

Displaying Results 451-475 of 2615 "'DNA'"

Apr 07, 2026, 08:00 ET Zymo Research and STORI Advance Early Pregnancy Detection with Cell-Free DNA Technology

sample preservation, cell-free DNA extraction chemistry, assay design, and computational analysis. Each stage of the workflow was engineered to enable reliable recovery and detection of low-abundance circulating DNA fragments during early gestation."Detecting fetal DNA at such early stages of pregnancy,

More news about: Zymo Research Corp.


Apr 06, 2026, 23:28 ET Akeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L)1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026

95.2%; the Objective Response Rate (ORR) was 26.2%, and the median Duration of Response (DoR) was 6.0 months. Patients who achieved circulating tumor DNA (ctDNA) clearance had a median PFS of 9.1 months. After the first treatment cycle (C1), the ctDNA detection rate decreased from 1.5% to 0.5%, demonstrating

More news about: Akeso, Inc.


Apr 06, 2026, 11:00 ET DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting

DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage whole-genome cell-free DNA (cfDNA)  assays for cancer detection and monitoring, today announced it will present five poster presentations at the

More news about: DELFI Diagnostics


Apr 06, 2026, 09:22 ET GA Group Acquires G2 Capital Advisors

Shribman, Chief Executive Officer of GA Group. "We have tremendous respect for what Jeffrey Unger and the G2 team have built. G2 shares GA Group's DNA - they bring deep, subject-matter expertise and 'been-in-your-shoes' advice from professionals who have spent their careers as operators and trusted

More news about: Great American Holdings, LLC


Apr 06, 2026, 07:30 ET The Flavor Experts Bring a Burst of Fresh, Bold Flavor with Citrus Mojo

delivering that bright, citrus-forward experience that fans have been clamoring for."At Wingstop, pushing the boundaries of flavor is in our DNA," said Donnie Upshaw, Chief Brand Officer of Wingstop. "Citrus Mojo brings a bright, refreshing profile into our flavor lineup while delivering the boldness

More news about: Wingstop Restaurants Inc.


Apr 04, 2026, 15:50 ET TriNetX 與 Regeneron 展開合作,獲取 3 億名患者的去識別化電子健康紀錄,以促進生命科學及數碼健康解決方案的研究與產品開發

數據私隱法例,包括《健康保險流通與責任法案》(HIPAA) 及《通用數據保障條例》(GDPR)。RGC 已開發出高通量且合乎成本效益的去氧核糖核酸 (DNA) 測序及蛋白質組學技術,並與全球超過 150 間生命科學及醫療保健合作機構合作,建立全球最大的電子健康紀錄連結測序及蛋白質組學數據庫。 與 TriNetX 的合作將有助 Regeneron 大幅擴大這個已是全球領先的數據集,從而繼續推動藥物探索與開發,同時亦為

More news about: TriNetX, LLC.


Apr 04, 2026, 15:50 ET A TriNetX colabora com a Regeneron para acessar prontuários eletrônicos de saúde desidentificados de 300 milhões de pacientes, motivando pesquisas e desenvolvimento de produtos em ciências da vida e soluções digitais de saúde

privacidade de dados aplicáveis, incluindo HIPAA e GDPR.O RGC desenvolveu abordagens de sequenciamento de DNA e proteômica de alto rendimento e econômicas para construir o maior banco de dados mundial de sequenciamento vinculado a EHR e proteômica, em colaboração

More news about: TriNetX, LLC.


Apr 03, 2026, 11:47 ET TriNetX arbeitet mit Regeneron zusammen, um Zugang zu anonymisierten elektronischen Patientenakten von 300 Millionen Patienten zu erhalten und damit die Forschung und Produktentwicklung in den Bereichen Biowissenschaften und digitale Gesundheitslösungen voranzutreiben

Zusammenarbeit mit über 150 Partnern aus den Bereichen Biowissenschaften und Gesundheitswesen weltweit hochdurchsatzfähige und kosteneffiziente Ansätze für die DNA-Sequenzierung und Proteomik entwickelt, um die weltweit größte Datenbank mit Sequenzierungs- und Proteomikdaten aufzubauen, die mit elektronischen Patientenakten

More news about: TriNetX, LLC.


Apr 03, 2026, 11:32 ET 트라이넷엑스, 리제네론과 협력해 3억 명의 비식별 전자 건강 기록에 접근… 생명과학 및 디지털 헬스 솔루션 분야의 연구 및 제품 개발 추진

데이터 프라이버시 법률에 따라 수행된다.RGC는 전 세계 150개 이상의 생명과학 및 의료 협력사와 협력해 세계 최대 규모의 EHR 연계 시퀀싱 및 단백질체 데이터베이스를 구축하기 위한 고처리량 및 비용 효율적인 DNA 시퀀싱 및 단백질체 접근 방식을 개발했다. 트라이넷엑스와의 협력은 리제네론이 이미 세계 최고 수준인 이 데이터 세트를 획기적으로 확장해 신약 발견 및 개발을 계속 추진하는 동시에,

More news about: TriNetX, LLC.


Apr 02, 2026, 16:30 ET TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

data privacy laws, including HIPAA and GDPR.The RGC has developed high-throughput and cost-efficient DNA sequencing and proteomics approaches to build the world's largest database of EHR-linked sequencing and proteomics data, in collaboration with over 150

More news about: TriNetX, LLC.


Apr 02, 2026, 16:30 ET TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

data privacy laws, including HIPAA and GDPR.The RGC has developed high-throughput and cost-efficient DNA sequencing and proteomics approaches to build the world's largest database of EHR-linked sequencing and proteomics data, in collaboration with over 150

More news about: TriNetX, LLC.


Apr 02, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO

development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papilloma virus ("HPV"). The Company's DNA medicines are comprised of two components: (i) DNA plasmids, which are small circular DNA molecules that purportedly work like

More news about: Pomerantz LLP


Apr 02, 2026, 09:43 ET ChillCo Logistics Partners with Mattingly Cold Storage to Launch Midwest Platform

partner with owner-operators across North America. Through its "Powered by ChillCo" model, partner brands stay front and center.Founded on operator DNA and a commitment to investing in people, ChillCo provides growth capital, operational resources, and flexible deal structures while preserving the teams,

More news about: ChillCo Logistics


Apr 02, 2026, 09:07 ET Illumina Announces Changes to Board of Directors

IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the

More news about: Illumina, Inc.


Apr 02, 2026, 09:03 ET Landmark Study of 20,000 Users Provides Peer-Reviewed Proof: InsideTracker's AI Health Platform Linked to Significant, Sustained Health Biomarker Improvements

clinical setting."InsideTracker is sitting on something genuinely rare: a longitudinal cohort that combines blood biomarkers, wearable data, DNA, and health surveys across tens of thousands of people over several years," said

More news about: InsideTracker


Apr 02, 2026, 09:00 ET Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City

diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to

More news about: Co-Diagnostics


Apr 02, 2026, 09:00 ET BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit 

More news about: BillionToOne


Apr 02, 2026, 08:55 ET INOVIO Announces Pricing of $17.5 Million Public Offering

biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting

More news about: INOVIO Pharmaceuticals, Inc.


Apr 02, 2026, 08:39 ET Global Food Safety Consultants (GFSC) Unveils 2026 Compliance Roadmap to Navigate SQF Edition 10 Transition

culture-driven safety standards. While many firms focus solely on passing an audit, GFSC's approach integrates these requirements into a company's daily DNA, ensuring compliance is a byproduct of excellence, not just a yearly hurdle."The 2026 landscape isn't just about checking boxes; it's about proving

More news about: Global Food Safety Consultants


Apr 02, 2026, 08:01 ET PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

Diagnostics Inc. (NASDAQ: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer

More news about: PAVmed Inc.


Apr 02, 2026, 08:00 ET Revlon Announces a Modern Take On "The Most Unforgettable Women in the World" to Inspire a Bold New Generation

introduces a modern visual language designed to capture the women's dimensionality – on camera and beyond. "We set out to honor Revlon's history and brand DNA while evolving the campaign through contemporary creative choices, including modern camera techniques," shared Lia Khayami Quiñones, Group Creative Director

More news about: Revlon


Apr 02, 2026, 07:30 ET Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

thicker plaques and lesions. This treatment approach avoids the risk of secondary malignancies (including melanoma) inherent with the frequently employed DNA-damaging drugs and other phototherapy that are dependent on ultraviolet exposure. Combined with photoactivation, hypericin has demonstrated significant

More news about: SOLIGENIX, INC.


Apr 02, 2026, 07:06 ET VML: World's first T-Rex leather product unveiled - a luxury handbag designed by Enfin Levé

modelling, scientists predicted and reconstructed the remaining genetic information required to form a complete collagen blueprint. This fully synthesized DNA was inserted into a carrier cell line. Billions of these engineered cells were then cultivated using Lab-Grown Leather's proprietary Advanced Tissue

More news about: VML


Apr 02, 2026, 06:30 ET Trimble to Acquire Document Crunch to Add AI-Powered Risk Management and Document Compliance to Trimble Construction One Project Delivery Ecosystem

Mark Schwartz, senior vice president of AECO software at Trimble. "Document Crunch will provide a 'contractual rule set' to serve as the intelligent DNA for the entire Trimble Construction One (TC1) suite, automatically pushing critical obligations, compliance requirements and payment terms into Trimble's

More news about: Trimble


Apr 01, 2026, 20:05 ET INOVIO Announces Proposed Public Offering

biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting

More news about: INOVIO Pharmaceuticals, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.